Prostate Cancer

ADT Therapy for Prostate Cancer Linked to Impaired Thinking

ADT Therapy for Prostate Cancer Linked to Impaired Thinking

Men with a particular gene mutation affected most, researchers find.

PCPs Screening Less with PSA Per USPSTF Recs

PCPs Screening Less with PSA Per USPSTF Recs

Primary care screening patterns have changed as a result of the USPSTF recommendation.

Salvage Cryo Outcomes Similar After EBRT, Brachytherapy

Salvage Cryo Outcomes Similar After EBRT, Brachytherapy

By

Study reveals comparable rates of freedom from biochemical failure at 5 years.

Early ADT for Recurrent Prostate Cancer May Hike Death Risk

Early ADT for Recurrent Prostate Cancer May Hike Death Risk

By

This effect appears to occur mainly in men who experience recurrence when they are younger than 65 and in those with low-risk cancer.

DRE Has Limited Value for Prostate Cancer Screening

DRE Has Limited Value for Prostate Cancer Screening

By

Biopsies triggered by an abnormal DRE alone were significantly less likely to detect clinically significant prostate cancer than biopsies triggered by an abnormal PSA alone.

Post-RP Outcomes Differ for Gleason 8, 9-10 Prostate Cancer

Post-RP Outcomes Differ for Gleason 8, 9-10 Prostate Cancer

By

Gleason 9-10 tumors are associated with a greater risk of biochemical and clinical recurrence, but not overall survival.

Radical Prostatectomy Offers Excellent Long-Term Outcomes

Radical Prostatectomy Offers Excellent Long-Term Outcomes

By

Researchers report on a study in which survivors were followed up for a median of 14 years.

Surgical Margin Status Has No Effect on PCa Patient Survival

Surgical Margin Status Has No Effect on PCa Patient Survival

By

Researchers concluded that margin status is a surrogate for established risk criteria.

Elevated NLR Linked to Worse Post-RP Outcomes

Elevated NLR Linked to Worse Post-RP Outcomes

By

Neutrophil-lymphocyte ratio could have a prognostic role in localized prostate cancer.

RALP Offers Favorable Long-Term Prostate Cancer Control

RALP Offers Favorable Long-Term Prostate Cancer Control

By

The 10-year rates of biochemical and clinical recurrence are comparable to those of open surgery.

PCa Metastasis Predictors in Active Surveillance Patients ID'd

PCa Metastasis Predictors in Active Surveillance Patients ID'd

By

A PSA doubling time of less than 3 years and a Gleason score of 8-10 were associated with an increased risk of metastasis.

PCa Active Surveillance Widely Used by Community Urologists

PCa Active Surveillance Widely Used by Community Urologists

By

Recent study shows that 71% of prostate cancer patients with very-low-risk disease were placed on active surveillance.

Adjuvant Radiation Therapy Underused in High-Risk PCa Patients

Adjuvant Radiation Therapy Underused in High-Risk PCa Patients

By

Only 7.4% of patients receive ART after radical prostatectomy despite the presence of adverse pathologic features, study shows.

Smoking Adversely Affects Urologic Surgery Outcomes

Smoking Adversely Affects Urologic Surgery Outcomes

By

Current and former smokers are at higher risk of complications within 30 days after radical prostatectomy or cystectomy.

Docetaxel and Hormone Therapy May Improve PCa Outcomes

Docetaxel and Hormone Therapy May Improve PCa Outcomes

Combination with hormone therapy can extend life by almost a year for prostate cancer patients

Statins May Help Prostate Cancer Patients on ADT

Statins May Help Prostate Cancer Patients on ADT

Prostate cancer remained stable for an average 10 extra months in men taking statins, but more trials are needed to confirm benefits, researchers say.

Prostate Cancer: The Price of Fitness?

Prostate Cancer: The Price of Fitness?

By

Although physical fitness is widely known to prevent cardiovascular disease, its impact on prostate cancer is less clear.

Quarter of Metastatic PCa Patients Had Synchronous Cancer

Quarter of Metastatic PCa Patients Had Synchronous Cancer

28.1% of patients with metastatic prostate cancer have a synchronous second primary cancer.

Under and Over Imaging in Castration-Resistant Prostate Cancer

Under and Over Imaging in Castration-Resistant Prostate Cancer

Patients with higher PSA, shorter PSA doubling time more likely to have second bone scan.

Walking Improves Wellbeing for Men with Prostate Cancer

Walking Improves Wellbeing for Men with Prostate Cancer

Researchers found real improvements in quality of life once men got active

Clinician-Referred Vigorous Exercise Good for Prostate Cancer Patients

Clinician-Referred Vigorous Exercise Good for Prostate Cancer Patients

Clinician referral to a 12-week program ups vigorous exercise levels and improves mental health.

Monitor Older Men on ADT for Diabetes and CVD

Monitor Older Men on ADT for Diabetes and CVD

Prolonged androgen deprivation treatment ups risk in older men with prostate cancer, especially those with comorbidities.

Prostate Cancer-Obesity Link Stronger in Blacks

Prostate Cancer-Obesity Link Stronger in Blacks

By

Obesity is associated with greater risk of PCa among African-American men compared to non-Hispanic white men.

Enzalutamide Improves Quality of Life in Chemo-Naive PCa Patients

Enzalutamide Improves Quality of Life in Chemo-Naive PCa Patients

Enzalutamide improves health-related quality of life (HRQoL) in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).

Aspirin Use Does Not Improve Prostate Cancer Mortality

Aspirin Use Does Not Improve Prostate Cancer Mortality

Increased risks of mortality restricted to aspirin use after the diagnosis of prostate cancer.

Repeat Prostate Biopsies Find Significant Cancers

Repeat Prostate Biopsies Find Significant Cancers

Increased likelihood of prostate cancer seen with fourth repeat biopsy, men.

Prostate Cancer Blood Test May Avert Biopsies

Prostate Cancer Blood Test May Avert Biopsies

By

The Prostate Health Index improves detection of clinically significant prostate cancer.

Time to PCa Metastasis Affects Overall Survival

Time to PCa Metastasis Affects Overall Survival

By

Median time to death was shortest in men with metastatic disease at diagnosis.

PCa Recurrence Not Linked to Metabolic Syndrome

PCa Recurrence Not Linked to Metabolic Syndrome

By

High LDL cholesterol and high blood glucose, however, did increase the risk of PSA relapse.

Fish Oil Might Reduce Chemo's Effectiveness

Fish Oil Might Reduce Chemo's Effectiveness

Research raises concern about the simultaneous use of chemotherapy and fish oil.

Sign Up for Free e-newsletters